Charles River Laboratories International - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CRL New York 2830 www.criver.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Charles River Laboratories International

3 Reasons to Sell CRL and 1 Stock to Buy Instead - Jun 17th, 2025 10:02 pm
3 Unpopular Stocks in Hot Water - Jun 16th, 2025 10:32 pm
Drug Development Inputs & Services Stocks Q1 Recap: Benchmarking Fortrea (NASDAQ:FTRE) - Jun 16th, 2025 9:38 pm
Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV) - Jun 16th, 2025 9:34 pm
Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment - Jun 16th, 2025 6:00 am
CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook - Jun 11th, 2025 3:28 am
Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report? - Jun 6th, 2025 9:31 am
1 Safe-and-Steady Stock Worth Your Attention and 2 to Steer Clear Of - Jun 5th, 2025 10:35 pm
Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers - Jun 3rd, 2025 9:32 pm
Drug Development Inputs & Services Q1 Earnings: UFP Technologies (NASDAQ:UFPT) Simply the Best - Jun 2nd, 2025 9:31 pm
Charles River Stock May Gain From Extended CHDI Research Deal on HD - Jun 2nd, 2025 6:12 am
Charles River Laboratories to Present at William Blair and Jefferies Conferences - Jun 2nd, 2025 6:00 am
1 Value Stock with Impressive Fundamentals and 2 to Steer Clear Of - Jun 1st, 2025 10:35 pm
Charles River Laboratories International, Inc. (CRL): A Bull Case Theory - May 29th, 2025 10:46 pm
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research - May 28th, 2025 6:00 am
Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT - May 24th, 2025 1:55 am
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know - May 21st, 2025 2:58 pm
Should You Continue to Hold Charles River Stock in Your Portfolio? - May 20th, 2025 6:53 am
Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL) - May 19th, 2025 9:34 pm
Understanding Charles River (CRL) Reliance on International Revenue - May 13th, 2025 7:16 am